Previous Close | 560.00 |
Open | 570.00 |
Bid | 570.00 x 10000 |
Ask | 580.00 x 10000 |
Day's Range | 570.00 - 570.00 |
52 Week Range | 454.00 - 605.00 |
Volume | |
Avg. Volume | 3 |
Market Cap | 8.916B |
Beta (5Y Monthly) | 0.42 |
PE Ratio (TTM) | 33.81 |
EPS (TTM) | 16.86 |
Earnings Date | Apr 24, 2024 |
Forward Dividend & Yield | 1.47 (0.26%) |
Ex-Dividend Date | Feb 23, 2024 |
1y Target Est | 577.25 |
If you're looking for a multi-bagger, there's a few things to keep an eye out for. In a perfect world, we'd like to see...
Investors are optimistic about Chemed (CHE), backed by the strong performance of the VITAS Healthcare and Roto-Rooter segments.
CINCINNATI, April 17, 2024--VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE) announced the completion of the previously announced purchase of all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. The transaction is structured as an asset purchase.